ArticleBMC research notes2026
Draft genome sequence of the fungal pathogen Fusarium oxysporum f. sp. cubense (MC3) isolated in Amazonas, Peru.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Draft genome sequence of the fungal pathogen Fusarium oxysporum f. sp. cubense (MC3) isolated in Amazonas, Peru.BMC research notes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study presents the genome sequencing of the MC3 strain of Fusarium oxysporum f. sp. cubense (Foc), isolated from damaged banana (Musa sp.) tissue from La Peca, Bagua city, Amazonas, Peru. The aim was to characterize the genome to understand the resistance and virulence potential of the isolate. DATA DESCRIPTION: The genomic DNA of the MC3 strain of Foc was sequenced using the Illumina platform, generating high-quality reads with an average genome coverage of 150 bp PE. Quality control was performed with FastQC, and the reads were preprocessed with Trimmomatic. De novo assembly was carried out with MaSuRCA, resulting in a draft genome of 45,518,950 bp assembled into 493 contigs with a GC content of 47.71%. Genome quality analysis revealed 99.2% completeness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.